Search Results

Lenalidomide (CC-5013) Evaluation Sample  | 98.66%

APEXBIO TECHNOLOGY LLC

Antineoplastic agent,inhibits angiogenesis Apoptosis|TNF-α

More Information Supplier Page

×

Lenalidomide (CC-5013)

Lenalidomide (CC-5013) 50mg  | 98.66%

APEXBIO TECHNOLOGY LLC

Antineoplastic agent,inhibits angiogenesis Apoptosis|TNF-α

More Information Supplier Page

×

Lenalidomide (CC-5013)

Lenalidomide (CC-5013) 100mg  | 98.66%

APEXBIO TECHNOLOGY LLC

Antineoplastic agent,inhibits angiogenesis Apoptosis|TNF-α

More Information Supplier Page

×

Lenalidomide (CC-5013)

Lenalidomide (CC-5013) 250mg  | 98.66%

APEXBIO TECHNOLOGY LLC

Antineoplastic agent,inhibits angiogenesis Apoptosis|TNF-α

More Information Supplier Page

×

Lenalidomide (CC-5013)

Bay 11-7821(BAY 11-7082) 100mg  | 99.89%

APEXBIO TECHNOLOGY LLC

IKK/NF-κB/TNFα inhibitor Immunology/Inflammation|IκB/IKK

More Information Supplier Page

×

Bay 11-7821(BAY 11-7082)

Bay 11-7821(BAY 11-7082) 50mg  | 99.89%

APEXBIO TECHNOLOGY LLC

IKK/NF-κB/TNFα inhibitor Immunology/Inflammation|IκB/IKK

More Information Supplier Page

×

Bay 11-7821(BAY 11-7082)

Bay 11-7821(BAY 11-7082) 25mg  | 99.89%

APEXBIO TECHNOLOGY LLC

IKK/NF-κB/TNFα inhibitor Immunology/Inflammation|IκB/IKK

More Information Supplier Page

×

Bay 11-7821(BAY 11-7082)

Bay 11-7821(BAY 11-7082) 10mg  | 99.89%

APEXBIO TECHNOLOGY LLC

IKK/NF-κB/TNFα inhibitor Immunology/Inflammation|IκB/IKK

More Information Supplier Page

×

Bay 11-7821(BAY 11-7082)

NSC 207895 (XI-006) 50mg  | 98%

APEXBIO TECHNOLOGY LLC

MDMX inhibitor,anti-cancer agent Apoptosis|MDM2

More Information Supplier Page

×

NSC 207895 (XI-006)

NSC 319726 10mM (in 1mL DMSO)  | 98%

APEXBIO TECHNOLOGY LLC

Reactivator of mutant p53 Apoptosis|p53

More Information Supplier Page

×

NSC 319726